Call Us Free: (800) 394-2767

Cambridge biotech Summit pivots from failed trial, layoffs with $4.5M from CARB-X

CARB-X’s $4.5 million award comes just a few weeks after the company shut down on a Duchenne muscular dystrophy trial and laid off most of their employees in Cambridge.

Source link

Leave a Reply